throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`CARDIOCOM, LLC
`Petitioner
`v.
`ROBERT BOSCH HEALTHCARE SYSTEMS, INC.
`Patent Owner
`_____________________
`CASE IPR2013-00451
`Patent No. 7,587,469
`_____________________
`
`PATENT OWNER’S MOTION FOR OBSERVATION REGARDING
`CROSS-EXAMINATION OF REPLY WITNESS DR. ROBERT STONE
`
`

`

`Pursuant to the Board’s January 16, 2014 Scheduling Order (Paper 24)
`
`authorizing a motion for observation regarding cross-examination of reply witness,
`
`Patent Owner Robert Bosch Healthcare Systems, Inc. (“Bosch”) provides the
`
`following observations on the July 15-17, 2014 cross-examination of Petitioner
`
`Cardiocom, LLC’s (“Cardiocom”) reply declarant, Dr. Robert Stone:
`
`Claim Limitations
`
`1.
`
`In Ex. 2024, at 920:8-921:14, Dr. Stone testifies:
`
`[Q.] Okay. So the high-level instruction or script file [in Wahlquist] is
`-- that would be a file of instructions to the computer; correct?
`A. Computer or could include instructions to the user to be displayed
`by the script file.
`Q. Displayed by the computer?
`A. Yes.
`Q. So either it’s an instruction for the computer to perform an
`operation or an instruction for the computer to display information to
`the user?
`A. That’s correct.
`Q. Okay. And similarly, if you look at the second portion you cited,
`Column 2, line 43 through 45.
`A. Yes.
`Q. That refers to the diagnostic program running on the user’s
`computer?
`A. It does.
`Q. The diagnostic program on the computer initiates execution of the
`
`-1 -
`
`

`

`script file?
`A. Yes.
`Q. The script file instructs the computer to execute the selected test?
`A. Yes.
`Q. So these are -- it’s referring to instructions to the user’s computer;
`correct?
`A. That’s correct.
`Q. Okay. So the portion that you refer to in Wahlquist, Column 2,
`lines 17 through 24 and Column 2, lines 43 through 45, are
`instructions given to the user’s computer to perform certain
`operations?
`A. That’s correct.
`
`This is relevant to ¶ 84 of Ex. 1022, where Dr. Stone argues that Wahlquist
`
`discloses receiving a computer program with instructions as required for the
`
`“primary device” in claim 1. This is relevant because Dr. Stone admits that the
`
`portions in Wahlquist that he relies upon disclose only instructions provided to a
`
`user’s computer—not instructions provided to the patient through synthesized
`
`audio transmissions as required for claim 1. See Ex. 1001, U.S. Patent No.
`
`7,587,469 (“ the ’469 patent”), 21:13-19 (“primary device comprises a component
`
`adapted to (i) receive one or more computer programs including one or more
`
`queries, instructions or messages as a first digital file from said server, (ii) convert
`
`the first digital file into synthesized audio transmissions”).
`
`2.
`
`In Ex. 2024, at 925:9-21, Dr. Stone testifies:
`
`-2 -
`
`

`

`[Q.] You are not saying that you have expressly set forth any opinion
`that quotes the language from the Claim 1 of the ’469 patent converts
`said first digital file into synthesized audio transmissions and
`identifies that as being part of either Cohen or Wahlquist?
`[A.] What I stated was I did not express an opinion with respect to
`what you just asked in the -- in the question.
`
`This is relevant to Dr. Stone’s obviousness opinions with respect to Cohen and
`
`Wahlquist (Ex. 1022 ¶¶ 50-103). This is relevant because Dr. Stone also admits
`
`that he does not set forth an opinion in his reply declaration that the combination of
`
`Cohen and Wahlquist discloses “convert[ing] the first digital file into synthesized
`
`audio transmissions” as required in claim 1. The ’469 patent, 21:13-19.
`
`Dr. Stone’s Incorrect Understanding of Analogous Art
`
`3.
`
`In Exhibit 2024, at 1142:9-24, Dr. Stone testified:
`
`Q. Okay. And you understand that only analogous art can be
`considered as part of an obviousness combination?
`A. No. I don’t understand that.
`Q. Okay. So --
`A. I understand that a reasonably pertinent art can be considered as
`part of an obviousness consideration. That’s my understanding.
`Q. Okay. So in forming your opinions, you had an understanding that
`art that was not necessarily analogous could still be considered as part
`of an obviousness combination?
`[A.] What I stated that I can use a reasonably pertinent reference that
`is not analogous is my understanding.
`
`-3 -
`
`

`

`This is relevant to Dr. Stone’s legal analysis of obviousness at ¶ 24 of Ex. 1022, his
`
`reply declaration. This is relevant because Dr. Stone applies a confused and
`
`incorrect legal standard with respect to the requirement that obviousness
`
`combinations must use analogous art. See In re Klein, 647 F.3d 1343, 1348 (Fed.
`
`Cir. 2011); In re Bigio, 381 F.3d 1320, 1325 (Fed. Cir. 2004).
`
`4.
`
`In Exhibit 2069, Dr. Stone testified:
`
`Q. So you’re not -- sitting here today, you’re not saying that
`Wahlquist is, quote/unquote, analogous art?
`[A.] I’m not prepared to give a -- the answer is I’m not saying that
`right now, yes. You’re correct. I am not saying that at the moment.
`
`Id., 1145:24-1146:5.
`
`Q. Wahlquist is directed to diagnosis and fixing computer problems?
`A. Certainly with regard to remote diagnosis of computer problems.
`Q. Wahlquist is not meant to monitor individuals?
`A. An individual human, no; an individual computer, yes.
`
`Id., 864:13-20.
`
`Q. Okay. And you agree that Wahlquist is not meant for monitoring
`individual humans?
`A. I tend to agree with that, yes.
`
`Id., 866:2-4. This is relevant to Dr. Stone’s usage of Wahlquist in obviousness
`
`combinations, on pages 10 and 30 of Ex. 1008, and his incorrect legal standard set
`
`forth in Ex. 2024, at 1142:9-24. This is relevant because Dr. Stone’s incorrect
`
`-4 -
`
`

`

`legal standard explains his usage of Wahlquist in obviousness combinations
`
`despite his testimony that Wahlquist is not analogous art.
`
`5.
`
`In Exhibit 2024, at 870:17-871:9 and 955:15-956:12, Dr. Stone
`
`testified that in considering the field of endeavor of a patent, he does not limit his
`
`analysis to the claimed invention:
`
`Q. And we have been talking about how you determine -- how you
`reached your opinion that Wahlquist was in the same field of
`endeavor as the ’469 patent, and that’s by comparing Wahlquist to the
`embodiments disclosed in the specification of the ’469 patent;
`correct?
`[A.] The embodiments and the stated application in the disclosure;
`that’s correct.
`[Q.] Yeah. But not limited to the invention claimed in the ’469 patent?
`A. No.
`Q. Okay. And then with respect to your opinion that Wahlquist is
`reasonably pertinent to the problems that the ’469 patent addresses,
`that was also based on your comparison of Wahlquist with the
`embodiments in the ’469 patent?
`A. That’s correct.
`
`Ex. 2024, 870:17-871:9.
`
`Q. Okay. And you have a broader understanding of the field of the
`invention of the ’186 patent than Dr. David and Bosch have?
`A. I do based on the disclosure of the ’186 patent.
`Q. And when you say “based on the disclosure of the ’186 patent,”
`
`-5 -
`
`

`

`you’re referring to the specification of figures of the ’186 patent?
`A. That’s correct.
`Q. You’re not limiting your understanding of the field of the ’186
`patent to the claims -- the scope of the claims of the ’186 patent, for
`example?
`[A.] I am not limiting it to those claims.
`[Q.] Your understanding of the field of invention of the ’186 patent is
`broader than what’s claimed in the claims of the ’186 patent?
`A. That is correct.
`Q. And you applied that understanding of the field of invention when
`you opined that Wahlquist is analogous prior art?
`A. I did.
`Id., 955:15-956:12;1 see also 959:25-960:4. This is relevant to Dr. Stone’s
`
`argument at pages 10 and 30 of Ex. 1008 that Wahlquist is a proper reference to
`
`use for obviousness. This is relevant because Dr. Stone failed to limit his analysis
`
`to the claimed invention. In re Klein, 647 F.3d at 1348 (“A reference qualifies as
`
`prior art for an obviousness determination under § 103 only when it is analogous to
`
`the claimed invention.”)
`
`Secondary Considerations of Non-Obviousness
`
`6.
`
`At Ex. 2024, at 879:2-8 and 884:14-885:16, Dr. Stone testified:
`
`1 While this testimony is related to the ’186 patent, Dr. Stone testified that he
`applies the same legal principles in forming his opinions with respect to the four
`patents at issue, including the ’469 patent. Ex. 2024, 1140:6-10.
`
`-6 -
`
`

`

`Q. So a person of ordinary skill in the art would have understood that
`there is a demand for products that would meet Claims 1, 2 and 5
`through 10 of the ’469 patent at the time of the invention of the ’469
`patent?
`[A.] A product, yes.
`
`Id., 879:2-8.
`
`Q. Okay. So a person of ordinary skill in the art would have
`understood that there was a need for a product that combines the
`teachings of Cohen and Wahlquist in the manner that you set forth in
`your declaration?
`[A.] Not only a need, but that it was obvious to do so, yes.
`[Q.] A person of ordinary skill in the art at the time of the ’469 patent
`would have understood that that need had existed for quite some time?
`[A.] Answer is yes.
`[Q.] And a person of ordinary skill in the art at the time of the ’469
`patent would understand that filling that need through an invention
`that would meet all the elements of Claims 1, 2 and 5 through 10 of
`the ’469 patent could help hospitals and medical providers who are
`under pressure to control their costs and who look to technology to do
`so?
`[A.] If they could come up with something that was truly an invention,
`that is true. That’s correct.
`
`Id., 884:14-885:16; see also id. 889:16-890:5. This is relevant to Dr. Stone’s
`
`overall opinions on obviousness (Ex. 1022 ¶¶ 50-103). This is relevant because
`
`Dr. Stone agrees that there was a long-felt need for the claimed inventions of the
`
`-7 -
`
`

`

`’469 patent, constituting evidence of secondary indicia of non-obviousness.
`
`7.
`
`At Ex. 2024, at 885:25-886:6, Dr. Stone testifies:
`
`[Q.] You’ve not identified in your new declaration anyone who
`developed a product that implemented Claims 1, 2 and 5 through 10
`of the ’469 patent either before or, for that matter, after the ’469
`patent issued?
`A. I have not set forth that in my declaration; that’s correct.
`
`See also id. 854:20-856:6. This is relevant to Dr. Stone’s discussion of
`
`motivations to combine the prior art (Ex. 1022 ¶¶ 63-73) because, despite this
`
`recognized long-felt need for the claimed invention, Dr. Stone admits he could find
`
`no single reference or system combining the same elements in the manner set forth
`
`in the ’469 patent prior to the invention of the patent.
`
`Dated: July 31, 2014
`
`Respectfully submitted,
`
`By:
`
`/Don Daybell/
`Don Daybell, Reg. No. 50,877
`Attorney for Patent Owner Robert Bosch
`Healthcare Systems, Inc.
`
`-8 -
`
`

`

`EXHIBIT LIST
`
`Exhibit No.
`
`Description
`
`Filed
`
`BOSCH 2001
`
`Affidavit of Bas De Blank
`
`BOSCH 2002
`
`Affidavit of Lillian Mao
`
`BOSCH 2003
`
`The New Shorter Oxford English
`Dictionary, 1993, pp. 606, 1271
`
`BOSCH 2004
`
`Harper Collins Dictionary of “Computer
`Terms,” 1991, p. 191
`
`BOSCH 2005
`
`Webster’s New World, “Computer
`Dictionary,” Tenth Edition, 2003, p. 298
`
`BOSCH 2006
`
`Affidavit of Bas De Blank
`
`BOSCH 2007
`
`Affidavit of Lillian Mao
`
`BOSCH 2008
`
`Affidavit of Siddhartha Venkatesan
`
`BOSCH 2009
`
`Dr. David’s Declaration
`
`BOSCH 2010
`
`Yadin B. David CV
`
`BOSCH 2011
`
`Deposition Transcript of Dr. Stone Taken on
`March , 7, 12 & 13, 2014
`
`BOSCH 2012
`
`Defendant’s Preliminary Claim
`Constructions and Disclosure of Extrinsic
`Evidence Pursuant to Local Patent Rule 4-2
`
`-9 -
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`

`

`Exhibit No.
`
`Description
`
`Filed
`
`BOSCH 2013
`
`BOSCH 2014
`
`BOSCH 2015
`
`BOSCH 2016
`
`Served on March 14, 2014
`
`Declaration by Matthew Might, PH.D
`Regarding Claim Constructions of Asserted
`Patents, filed on March 14, 2014
`
`Declaration by Robert T. Stone, PH.D
`Regarding U.S. Patent No. 7,587,469 Under
`37 C.F.R. § 42.63 (a), dated February 13,
`2014
`
`Declaration by Robert T. Stone, PH.D
`Regarding U.S. Patent No. 7,870,249 Under
`37 C.F.R. § 42.63 (a), dated April 9, 2014
`
`Declaration of Robert T. Stone, Ph.D in
`Support of Petition for Inter Partes Review
`of U.S. Patent No. 7,870,249, dated April
`24, 2014
`
`BOSCH 2017
`
`Deposition Errata Sheets of Dr. Stone
`
`BOSCH 2018
`
`Supplemental Declaration Responding to
`Patent Owner Contentions By Robert T.
`Stone, Ph.D. Regarding U.S. Patent No.
`7,587,469 Under 37 C.F.R. § 42.63(a)
`
`BOSCH 2019
`
`Medtronic’s Petition for Inter Partes Review
`Under 37 C.F.R. § 42.100, filed on April 10,
`2014
`
`BOSCH 2020
`
`Medtronic’s Petition for Inter Partes Review
`Under 37 C.F.R. § 42.100, filed on April 25,
`
`-10 -
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`

`

`Exhibit No.
`
`Description
`
`Filed
`
`2014
`
`BOSCH 2021
`
`BOSCH 2022
`
`Declaration by Robert T. Stone, Ph.D
`Regarding U.S. Patent No. 7,516,192 Under
`37 C.F.R. § 42.63(a), dated July 19, 2013
`
`Declaration by Robert T. Stone, Ph.D
`Regarding U.S. Patent No. 7,921,186 Under
`37 C.F.R. § 42.63(a), dated July 11, 2013
`
`BOSCH 2023
`
`Signature Pages to Dr. David’s Depositions
`
`BOSCH 2024
`
`Deposition Transcript of Dr. Stone Taken on
`July 15, 16 & 17, 2014
`
`BOSCH 2025
`
`BOSCH 2026
`
`Patent Owner’s Objections to Evidence
`Submitted by Cardiocom, LLC With
`Respect to U.S. Patent No. 7,587,469, filed
`July 9, 2014
`
`Patent Owner’s Objections to Evidence
`Submitted by Cardiocom, LLC With
`Respect to U.S. Patent No. 7,587,469, filed
`June 17, 2014
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`-11 -
`
`

`

`CERTIFICATION OF SERVICE (37 C.F.R. §§ 42.6(e))
`
`The undersigned hereby certifies that the above-captioned PATENT
`
`OWNER’S MOTION FOR OBSERVATION REGARDING CROSS-
`
`EXAMINATION OF REPLY WITNESS DR. ROBERT STONE and Exhibits
`
`2012-2022 and 2024-2026 were served in its entirety on July 31, 2014, upon the
`
`following parties via electronic mail:
`
`Counsel for Petitioner
`
`Daniel W. McDonald
`Andrew J. Lagatta
`Merchant & Gould
`80 South 8th St., Suite 3200
`Minneapolis, MN 55402
`CardiocomIPR@merchantgould.com
`
`By:
`
`/Karen Johnson/
`Karen Johnson
`
`-12 -
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket